SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-256118
Filing Date
2022-10-03
Accepted
2022-10-03 07:09:56
Documents
16
Period of Report
2022-10-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d403545d8k.htm   iXBRL 8-K 54585
2 EX-2.1 d403545dex21.htm EX-2.1 644674
3 EX-99.2 d403545dex992.htm EX-99.2 64899
4 EX-99.1 d403545dex991.htm EX-99.1 76924
5 EX-99.3 d403545dex993.htm EX-99.3 15915
  Complete submission text file 0001193125-22-256118.txt   1203411

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA logc-20221003.xsd EX-101.SCH 2860
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE logc-20221003_lab.xml EX-101.LAB 18738
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE logc-20221003_pre.xml EX-101.PRE 11710
10 EXTRACTED XBRL INSTANCE DOCUMENT d403545d8k_htm.xml XML 3470
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Filer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38707 | Film No.: 221285924
SIC: 2836 Biological Products, (No Diagnostic Substances)